News for APYP Stock

AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring AppYea Chairman Bary Molchadsky Demonstrates Confidence by Converting Debt to Warrants with a Strike Price Set at a 250% Premium to Current Market Price of the Company’s Common Stock AppYea Launches E-Commerce Store on Amazon Broadening Distribution AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S. AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024 AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair SleepX has Started Marketing its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback